Valganciclovir
Valhit belongs to a group of medicines that work directly to prevent viruses from multiplying. Valganciclovir, the active substance in the tablets, is converted in the body to ganciclovir. Ganciclovir prevents the cytomegalovirus (CMV) from multiplying and infecting healthy cells in the body. In patients with weakened immune systems, CMV can cause infections in various organs. This can be life-threatening.
Valhit is used:
Before taking Valhit, talk to your doctor or pharmacist.
Tell your doctor or pharmacist about all the medicines you are taking, have recently taken, or might take, including those obtained without a prescription.
Taking Valhit with other medicines can affect the levels of the medicine in your blood and may cause harmful side effects. If you are currently taking a medicine that contains any of the following active substances, tell your doctor:
Take Valhit with food. If you cannot eat for any reason, you should still take your prescribed dose of Valhit.
If you are pregnant, do not take Valhit unless your doctor advises you to. If you are pregnant or planning to become pregnant, tell your doctor before taking Valhit. Taking Valhit during pregnancy may harm your unborn baby.
Do not take Valhit while breastfeeding. If your doctor wants you to start treatment with Valhit, you should stop breastfeeding before starting to take this medicine.
Women of childbearing age must use effective contraception during treatment with Valhit and for at least 30 days after treatment.
If you are a man taking Valhit, you should use a condom during sexual intercourse with a woman who could become pregnant, during treatment and for 90 days after treatment.
Do not drive or operate any tools or machines if you experience dizziness, tiredness, tremors, or confusion while taking Valhit.
Before taking any medicine, consult your doctor or pharmacist.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
Handle the tablets with care. Do not break or crush them. Swallow the tablets whole, if possible, with food. If you accidentally touch a broken tablet, wash your hands thoroughly with soap and water. If the powder from the tablet gets into your eyes, rinse them thoroughly with sterile water or, if not available, clean water.
Take Valhit tablets with food, if possible - see section 2.
Start taking Valhit within 10 days after transplantation. The usual recommended dose is 2 tablets ONCE a day. Continue taking this dose for 100 days.
In patients who have received a kidney transplant, your doctor may recommend taking the tablets for 200 days.
The typical dose of Valhit is 2 tablets TWICE a day for 21 days (3 weeks). Unless your doctor advises otherwise, do not take this dose for more than 21 days, as this may increase the risk of side effects.
The typical dose of Valhit is 2 tablets ONCE a day. Try to take the tablets at the same time each day. Your doctor will decide how long you should take Valhit. If your retinitis worsens while taking this dose, your doctor may recommend repeating the induction treatment (as above) or decide to give you another medicine to treat the CMV infection.
Valhit has not been studied in elderly patients.
In patients with kidney problems, your doctor may recommend taking a lower dose or taking the tablets only on certain days of the week. It is very important to take the exact dose prescribed by your doctor.
Valhit has not been studied in patients with liver problems.
Start giving Valhit to the child within 10 days after transplantation. The recommended dose may vary depending on the size of the child and should be taken ONCE a day.
Your doctor will choose the right dose based on the child's height, weight, and kidney function. Continue giving this dose for 100 days. If the child has received a kidney transplant, your doctor may recommend taking the tablets for 200 days.
If the child cannot swallow the film-coated Valhit tablets, valganciclovir can be given as an oral solution.
If you have taken more tablets than prescribed, contact your doctor or go to the hospital immediately. Taking more than the prescribed dose may cause serious side effects, especially affecting your blood or kidneys.
Hospital treatment may be necessary.
If you forget to take a tablet, take the missed dose as soon as possible and then take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
Do not stop taking Valhit unless your doctor advises you to.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Valhit can cause side effects, although not everybody gets them.
Severe allergic reactions to valganciclovir (anaphylaxis) occur in less than 1 in 1000 patients. If you experience any of the following symptoms, stop taking Valhit and go to the hospital immediately:
Tell your doctor immediately if you experience any of the following side effects - your doctor may advise you to stop taking Valhit and may need to give you urgent treatment:
Very common:may affect more than 1 in 10 people
low white blood cell count - signs of infection such as sore throat, mouth ulcers, or fever
low red blood cell count - symptoms may include shortness of breath or feeling tired, fast heartbeat, or pale skin
Common:may affect up to 1 in 10 people
blood infection (sepsis) - symptoms include fever, chills, fast heartbeat, confusion, and slurred speech
low platelet count - symptoms may include easy bruising or bleeding, blood in urine or stools, or bleeding from the gums; bleeding may be severe
severe decrease in blood cell counts
pancreatitis - symptoms include stomach pain that radiates to the back
seizures
Uncommon:may affect up to 1 in 100 people
bone marrow failure
hallucinations - hearing or seeing things that do not exist
thought or mood disorders, loss of contact with reality
kidney problems
Tell your doctor, pharmacist, or nurse if you experience any of the following side effects:
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Detachment of the inner layer of the eye (retinal detachment) has occurred only in AIDS patients treated with Valhit for CMV infection.
Side effects in children and adolescents are similar to those in adults.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Side effects can be reported to the national reporting system via the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card Scheme (www.mhra.gov.uk/yellowcard). You can also report side effects directly to the manufacturer.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
No special storage precautions are required.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Valhit is available as film-coated tablets. The tablets are described below.
Valhit tablets are pink, oval, biconvex (16.7 x 7.8 mm), with "J" engraved on one side and "156" on the other side.
Blister pack (OPA/Aluminium/PVC/Aluminium) in a cardboard box. The pack contains 30, 60, 90, or 120 tablets.
HDPE bottle with a PP cap and a child-resistant closure, in a cardboard box. The pack contains 60 tablets.
Not all pack sizes may be marketed.
Accord Healthcare Polska Sp. z o.o.
Taśmowa 7
02-677 Warsaw
Pharmadox Healthcare Limited
KW20A Kordin Industrial Park
Paola, PLA 3000
Malta
Accord Healthcare Polska Sp. z o.o.
Lutomierska 50
95-200 Pabianice
Accord Healthcare B.V
Winthontlaan 20
3526 KV Utrecht
Netherlands
Accord Healthcare Polska Sp. z o.o.
Taśmowa 7, 02-677 Warsaw
tel: +48 22 577 28 00
fax: + 48 22 577 29 01
Member State | Marketing authorisation holder |
Austria | Valganciclovir Accord 450 mg filmtabletten |
Cyprus | Valganciclovir Accord 450 mg film coated tablets |
Czech Republic | Virexan 450 mg |
Denmark | Valganciclovir Accord 450 mg filmovertrukne tabletter |
Estonia | Valganciclovir Accord |
Finland | Valganciclovir Accord 450 mg tabletti, kalvopäällysteinen |
France | Valganciclovir Accord 450 mg comprimé pelliculé |
Netherlands | Valganciclovir Accord 450 mg filmomhulde tabletten |
Spain | Valganciclovir Accord 450 mg comprimidos recubiertos con película |
Ireland | Valganciclovir 450 mg film-coated tablets |
Lithuania | Valganciclovir Accord 450 mg plėvele dengtos tabletės |
Latvia | Valganciclovir Accord 450 mg apvalkotās tabletes |
Malta | Valganciclovir 450 mg film-coated tablets |
Norway | Valganciclovir Accord |
Poland | Valhit |
Portugal | Valganciclovir Accord |
Sweden | Valganciclovir Accord 450 mg filmdragerade tabletter |
United Kingdom | Valganciclovir 450 mg film-coated tablets |
Italy | Valganciclovir Accord |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.